Phase 0/1 of Positron Emission Tomography (PET) imaging agent [18F]-ODS2004436 as a marker of EGFR mutation in patients with non-small cell lung cancer (NSCLC)
| Autor: | Yann Bouvet, Jan Hoflack, Jean-Bernard Deloye, Alexandre Cochet, Nicolas Isambert, Philippe Genne, Petra Blom, Charles Coutant, Aurélie Bertaut, Cyril Berthet, Pascal Foucher, Gilles Viot, Jean-Marc Vrigneaud, Bruno Coudert, Pierre Fumoleau |
|---|---|
| Přispěvatelé: | université de Bourgogne, LE2I, Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon] (UNICANCER/CRLCC-CGFL), UNICANCER, Laboratoire d'Electronique, d'Informatique et d'Image [EA 7508] (Le2i), Université de Technologie de Belfort-Montbeliard (UTBM)-Université de Bourgogne (UB)-École Nationale Supérieure d'Arts et Métiers (ENSAM), Arts et Métiers Sciences et Technologies, HESAM Université (HESAM)-HESAM Université (HESAM)-Arts et Métiers Sciences et Technologies, HESAM Université (HESAM)-HESAM Université (HESAM)-AgroSup Dijon - Institut National Supérieur des Sciences Agronomiques, de l'Alimentation et de l'Environnement-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Oncodesign [Dijon], Cyclopharma, European-Association-of-Nuclear-Medicine (EANM) |
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| Předmět: |
Cancer Research
[SDV.IB.IMA]Life Sciences [q-bio]/Bioengineering/Imaging non-small cell lung cancer (NSCLC) [SDV.IB.MN]Life Sciences [q-bio]/Bioengineering/Nuclear medicine [SDV.IB.MN] Life Sciences [q-bio]/Bioengineering/Nuclear medicine 03 medical and health sciences 0302 clinical medicine medicine In patient ComputingMilieux_MISCELLANEOUS medicine.diagnostic_test business.industry Pet imaging medicine.disease EGFR Tyrosine Kinase Inhibitors respiratory tract diseases 3. Good health [SDV.IB.IMA] Life Sciences [q-bio]/Bioengineering/Imaging Oncology Egfr mutation Positron emission tomography 030220 oncology & carcinogenesis Mutation (genetic algorithm) Cancer research business 030215 immunology |
| Zdroj: | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) 31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), European-Association-of-Nuclear-Medicine (EANM), Oct 2018, Dusseldorf, Germany. pp.S172 / Meeting Abstract: OP-523 |
| DOI: | 10.1007/s00259-018-4148-3 |
| Popis: | e24184Background: Multiple EGFR tyrosine kinase inhibitors (TKIs) are approved for treatment of NSCLC harboring EGFR activating mutations or secondary TKIs resistant mutation. We evaluate a new PET... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|